Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q3 2020 Earnings Conference Call November 5, 2020 4:30 PM ET Company Participants Sara Pellegrino - VP, IR & Public Relations Maria Fardis - CEO, President & Director Friedrich Finckenstein - Chief Medical Officer Michael Swartzburg - VP, Finance and Interim Principal Financial Officer & Principal Accounting Officer Conference Call Participants Peter Lawson - Barclays Bank Mara Goldstein - Mizuho Securities Mark Breidenbach - Oppenheimer Boris Peaker - Cowen and C ...